The discovery of a 'biomarker panel' could have a profound impact on the ability to identify patients at risk of developing PC at an earlier stage.

The emergence of generative artificial intelligence as a transformative force is reshaping how software is developed and ...

Eran Ovadya, Chief Financial Officer of NurExone stated, “The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.

SAN FRANCISCO-- ( BUSINESS WIRE )-- 6sense ®, the leading platform revolutionizing B2B revenue generation, today released its ...

Viral diseases remain a significant global health challenge, causing widespread morbidity and mortality. Advances in ...